These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1972560)

  • 1. The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots.
    Green PM; Montandon AJ; Bentley DR; Ljung R; Nilsson IM; Giannelli F
    Nucleic Acids Res; 1990 Jun; 18(11):3227-31. PubMed ID: 1972560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene.
    Bottema CD; Ketterling RP; Vielhaber E; Yoon HS; Gostout B; Jacobson DP; Shapiro A; Sommer SS
    Hum Genet; 1993 Jun; 91(5):496-503. PubMed ID: 8314564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype analysis of identical factor IX mutants using PCR.
    Green PM; Montandon AJ; Ljung R; Nilsson IM; Giannelli F
    Thromb Haemost; 1992 Jan; 67(1):66-9. PubMed ID: 1615486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of haemophilia B database and strategies for identification of common point mutations in the factor IX gene.
    Mukherjee S; Mukhopadhyay A; Chaudhuri K; Ray K
    Haemophilia; 2003 Mar; 9(2):187-92. PubMed ID: 12614370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.
    Koeberl DD; Bottema CD; Ketterling RP; Bridge PJ; Lillicrap DP; Sommer SS
    Am J Hum Genet; 1990 Aug; 47(2):202-17. PubMed ID: 2198809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.
    Mårtensson A; Letelier A; Halldén C; Ljung R
    Haemophilia; 2016 May; 22(3):440-5. PubMed ID: 26612714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and molecular biology of haemophilias A and B.
    Green PM; Montandon AJ; Bentley DR; Giannelli F
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):539-65. PubMed ID: 1768766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why does the human factor IX gene have a G + C content of 40%?
    Bottema CD; Bottema MJ; Ketterling RP; Yoon HS; Janco RL; Phillips JA; Sommer SS
    Am J Hum Genet; 1991 Oct; 49(4):839-50. PubMed ID: 1897528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methylation of the factor IX gene--a basic reason for the mutation causing hemophilia B].
    Mazin AL
    Mol Biol (Mosk); 1995; 29(1):71-90. PubMed ID: 7723765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG.
    Koeberl DD; Bottema CD; Buerstedde JM; Sommer SS
    Am J Hum Genet; 1989 Sep; 45(3):448-57. PubMed ID: 2773937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent mutations in the factor IX gene: founder effect or repeat de novo events. Investigation of the German haemophilia B population and review of de novo mutations.
    Knobloch O; Zoll B; Zerres K; Brackmann HH; Olek K; Ludwig M
    Hum Genet; 1993 Aug; 92(1):40-8. PubMed ID: 8365725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic diagnosis in haemophiliacs (haemophilia A, B, carrier)].
    Mikami S
    Rinsho Byori; 1990 Jun; Suppl 85():102-13. PubMed ID: 1976834
    [No Abstract]   [Full Text] [Related]  

  • 13. The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model.
    Sved J; Bird A
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4692-6. PubMed ID: 2352943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequence analysis of three inhibitor-positive hemophilia B patients without gross gene deletion: identification of four novel mutations in factor IX gene.
    Matsushita T; Tanimoto M; Yamamoto K; Sugiura I; Hamaguchi M; Takamatsu J; Kamiya T; Saito H
    J Lab Clin Med; 1990 Oct; 116(4):492-7. PubMed ID: 2212858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence specificity in CpG mutation hotspots.
    Ollila J; Lappalainen I; Vihinen M
    FEBS Lett; 1996 Nov; 396(2-3):119-22. PubMed ID: 8914970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of factor IX gene mutations causing haemophilia B from India.
    Ghosh K; Quadros L; Shetty S
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):333-6. PubMed ID: 19357501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haemophilia].
    Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K
    Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation rates in humans. II. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from hemophilia B.
    Giannelli F; Anagnostopoulos T; Green PM
    Am J Hum Genet; 1999 Dec; 65(6):1580-7. PubMed ID: 10577911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier detection and prenatal diagnosis in haemophilia A and B.
    Chistolini A; Papacchini M; Mazzucconi MG; La Verde G; Arcieri R; Ferrari A; Paesano R; Pachi A; Mariani G
    Haematologica; 1990; 75(5):424-8. PubMed ID: 1982946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.